Pelareorep synergizes with azacitidine The trial being stopped, ENHANCE, was studying the use ofs magrolimab plus a type of chemotherapy called azacitidine (Vidaza) in patients with higher-risk myelodysplastic syndromes, or MDS.
I always found it interesting that when magrolimab study was stopped by FDA temporary the first time
We had a press release around the same time that said Pelareorep was synergistic in leukemia with azacitidine but we didn't get noticed really.
https://www.newswire.ca/news-releases/oncolytics-biotech-r-announces-the-presentation-of-preclinical-data-demonstrating-the-synergistic-anti-leukemic-effects-of-pelareorep-combined-with-azacitidine-at-the-2021-american-society-of-hematology-annual-meeting-889202448.html